These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Radiofrequency ablation: a minimally invasive technique with multiple applications. Bilchik AJ; Rose DM; Allegra DP; Bostick PJ; Hsueh E; Morton DL Cancer J Sci Am; 1999; 5(6):356-61. PubMed ID: 10606477 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience. Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061 [TBL] [Abstract][Full Text] [Related]
9. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Wettstein M; Vogt C; Cohnen M; Brill N; Kurz AK; Mödder U; Häussinger D Hepatogastroenterology; 2004; 51(57):830-2. PubMed ID: 15143927 [TBL] [Abstract][Full Text] [Related]
12. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Berber E; Ari E; Herceg N; Siperstein A Surg Endosc; 2005 Dec; 19(12):1613-7. PubMed ID: 16247574 [TBL] [Abstract][Full Text] [Related]
13. Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms. Berber E; Herceg NL; Casto KJ; Siperstein AE Surg Endosc; 2004 Mar; 18(3):390-6. PubMed ID: 14735342 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. Blonski WC; Reddy KR; Shaked A; Siegelman E; Metz DC World J Gastroenterol; 2005 Dec; 11(48):7676-83. PubMed ID: 16437698 [TBL] [Abstract][Full Text] [Related]